title: Is administration of rituximab at 375 mg/m without splenectomy appropriate for ABO-incompatible renal transplant?
authors.forename: N
authors.initials: N
authors.lastname: Mitsuhata
authors.forename: R
authors.initials: R
authors.lastname: Fujita
authors.forename: S
authors.initials: S
authors.lastname: Ito
authors.forename: M
authors.initials: M
authors.lastname: Mannami
authors.forename: K
authors.initials: K
authors.lastname: Kojima
mesh_terms: D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D001787:Blood Group Incompatibility / Q000188:drug therapy*; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D016030:Kidney Transplantation; D000069283:Rituximab; D013156:Splenectomy
chemical_list: D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab